Oncology & Cancer

MRI frequently underestimates tumor size in prostate cancer

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

Oncology & Cancer

Evaluating the 'financial toxicity' of prostate cancer treatment

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). ...

page 1 from 12